What are the Challenges Faced by Patent Holders in Cancer Research?
Patent holders in cancer research face several challenges. One major issue is the lengthy and costly process of clinical trials required to bring a new cancer treatment to market. Additionally, there is often public and ethical debate over the patenting of genetic sequences, as some argue that genes are naturally occurring and should not be owned. Furthermore, the high cost of patented treatments can limit their accessibility to patients, raising concerns about healthcare equity.
